Contribution: Industrial Research Assistance Program – Contributions to Firms
Opportune Therapeutics Inc
$50,000.00
Cannabis Compound – Human Receptor Knowledgebase
FY 2019-20 · 2019-06-03
Summary
Development of a comprehensive molecular knowledgebase linking cannabis compounds to human receptors and their associated therapeutic indications.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Lasalle|Lasalle, Quebec, Canada
Recipient Type
For-profit organization
Business Number
763159480
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-06-03 | 2019-20 | $50,000.00 |
| 1 | 2019-06-03 | 2019-20 | $50,000.00 |
As published
Agreement End Date
2020-03-06
Agreement Number
929618
Agreement Start Date
2019-06-03
Agreement Title
Cannabis Compound – Human Receptor Knowledgebase
Agreement Title (French)
Composé du cannabis - Base de connaissances sur les récepteurs humains
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2019-06-03
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of a comprehensive molecular knowledgebase linking cannabis compounds to human receptors and their associated therapeutic indications.
Description (French)
Développement d'une base de connaissances moléculaires complète reliant les composés du cannabis aux récepteurs humains et leurs indications thérapeutiques associées.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vimy
Federal Riding (French)
Vimy
Federal Riding Number
24078
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
763159480
Recipient City
Lasalle|Lasalle
Recipient Country
CA
Recipient Legal Name
Opportune Therapeutics Inc
Recipient Postal Code
H7S 2E4
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2019-2020-Q2-929618
